Association between the Epidermal Growth Receptor Status and the Efficacy of First-line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
Background and objective Status of epidermal growth factor receptor (EGFR) gene is a predictor of response to EGFR tyrosine kinase inhibitor (TKI). However, little is know about the relationship between EGFR status and response to chemotherapy. We evaluated the prediction value of EGFR mutation stat...
Main Authors: | Na QIN, Quan ZHANG, Jinghui WANG, Hui ZHANG, Yanfei GU, Xinjie YANG, Xi LI, Jialin LV, Yuhua WU, Jingying NONG, Xinyong ZHANG, Shucai ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-03-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.03.02 |
Similar Items
-
Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation
by: Quan ZHANG, et al.
Published: (2016-05-01) -
Clinical Observation of Icotinib Hydrochloride for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified
by: Xi LI, et al.
Published: (2015-12-01) -
Clinical Observation of Icotinib Hydrochloride in First-line Therapy
for Pulmonary Adenocarcinoma
by: Xinjie YANG, et al.
Published: (2013-07-01) -
Effectiveness of EGFR-TKIs versus Chemotherapy as First-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis
by: Feifei CAO, et al.
Published: (2015-03-01) -
First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Qiang Wu, et al.
Published: (2021-04-01)